China Valuations Looking More Reasonable: Macquarie – ValueWalk Premium
China A and H-share performance

China Valuations Looking More Reasonable: Macquarie

Following the recent 20% stock market correction, valuations in China look a good deal more reasonable, although current multiples for Staples, Healthcare and IT still look stretched, notes Macquarie.

Joshua van Lin of Macquarie Capital Securities in the Asia strategy research report titled: “China: Taking stock”, notes ROE erosion in big SOE sectors is a drag on MSCI China.
Most China stocks now at reasonable valuations
Drawing attention to Macquarie’s April 30, 2015 report titled: “Are H-shares overvalued?”, the analyst recalls the . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email support@valuewalk.com or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

The top investors are reading ValuewalkPremium.

Click here to learn why

0